| Size | Price | |
|---|---|---|
| 500mg | ||
| 1g | ||
| Other Sizes |
| Targets |
5-HT2 receptors (antagonist; Ki ~62 nM); muscarinic M1, M2, M3 receptors (Kis 25, 60, 6 nM); histamine H1 receptor (antagonist); 5-HT1 receptor (weak, Ki ~2900 nM).
|
|---|---|
| ln Vitro |
Drug compounds have included stable heavy isotopes of carbon, hydrogen, and other elements, mostly as quantitative tracers while the drugs were being developed. Because deuteration may have an effect on a drug's pharmacokinetics and metabolic properties, it is a cause for concern [60].
Cyclobenzaprine binds strongly to 5-HT2 receptors with a Ki of 62 nM and to 5-HT1 receptors with a Ki of 2900 nM. It antagonizes muscarinic receptors with Ki values of 25 nM (M1), 60 nM (M2), and 6 nM (M3), and 5-HT2C and 5-HT2B receptors with Kis of 56 nM and 330 nM, respectively. Its metabolite norcyclobenzaprine also exhibits high affinity for 5-HT2A, H1, and M1 receptors. |
| ln Vivo |
In vivo, cyclobenzaprine reduces skeletal muscle hyperactivity through central 5-HT2 receptor antagonism. It produces sedation and has been investigated for fibromyalgia and sleep disturbances. The labeled form is used for pharmacokinetic profiling.
|
| Enzyme Assay |
Radioligand binding assays use membrane preparations from cells expressing recombinant 5-HT2A, 5-HT2C, 5-HT2B, M1–M5, or H1 receptors and appropriate radiolabeled antagonists (e.g., [³H]-ketanserin for 5-HT2A, [³H]-N-methylscopolamine for muscarinic receptors, [³H]-pyrilamine for H1). Competition curves yield Ki values.
|
| Cell Assay |
In vitro functional assays use isolated guinea pig ileum or rat fundus strips to assess 5-HT2 receptor–mediated contraction, and cells expressing recombinant receptors to measure 5-HT2-mediated phosphoinositide turnover or muscarinic-mediated cAMP modulation. Cyclobenzaprine (0.1 nM–10 µM) is tested for antagonist activity.
|
| Animal Protocol |
Rodent models of muscle spasm or pain receive cyclobenzaprine by oral or intraperitoneal administration at 1–10 mg/kg. Muscle tone is assessed by electromyography, and behavioral sedation is scored. Plasma and brain concentrations are quantified by LC-MS/MS using the ¹³C,d3-labeled internal standard.
|
| References |
|
| Molecular Formula |
C1913CH19D3CLN
|
|---|---|
| Molecular Weight |
315.86
|
| CAS # |
1261394-10-8
|
| Related CAS # |
Cyclobenzaprine hydrochloride;6202-23-9
|
| Appearance |
Typically exists as solid at room temperature
|
| SMILES |
[2H][13C]([2H])([2H])N(C)CC/C=C1C2=CC=CC=C2C=CC3=CC=CC=C3/1.Cl
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.1660 mL | 15.8298 mL | 31.6596 mL | |
| 5 mM | 0.6332 mL | 3.1660 mL | 6.3319 mL | |
| 10 mM | 0.3166 mL | 1.5830 mL | 3.1660 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.